Our friend bbooooooya notes an interesting contrast:
The CEO of Synta Pharmaceuticals was invited to the President's speech last night; his company put out a press release about it:
"Maintaining U.S. leadership in science and technology and addressing the serious healthcare issues facing this country require policies in place that encourage innovation," said Dr. Bahcall. "Reducing the barriers and increasing incentives to innovation can help companies like Synta and other biotechnology companies create new drugs, lower the total costs of healthcare by preventing expensive hospital stays and create new jobs in America."
Oh, what's this? An article from 2008 in Pharmaceutical Outsourcing by your director of preclinical development?
This article will not be a general review of quality/capability of Chinese CROs/CMOs, but will describe how Synta came to recognize China as a feasible pre/nonclinical outsourcing option through evaluating our partnership with several CROs and CMOs located in China.
Well, I'm sure that once Synta gets its tax credits, the money will all be spent here to hire American scientists. And a pony.